Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001178913-26-000663
Filing Date
2026-03-02
Accepted
2026-03-02 07:16:01
Documents
86
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 20-F zk2634416.htm   iXBRL 20-F 2483944
2 EXHIBIT 8.1 exhibit_8-1.htm EX-8.1 2372
3 EXHIBIT 11.B exhibit_11-b.htm EX-11 67528
4 EXHIBIT 12.1 exhibit_12-1.htm EX-12.1 7442
5 EXHIBIT 12.2 exhibit_12-2.htm EX-12.2 7406
6 EXHIBIT 13.1 exhibit_13-1.htm EX-13.1 3966
7 EXHIBIT 15.1 exhibit_15-1.htm EX-15.1 3953
13 GRAPHIC image00001.jpg GRAPHIC 6053
  Complete submission text file 0001178913-26-000663.txt   9745749

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE cgen-20251231.xsd EX-101.SCH 66990
9 XBRL CALCULATION FILE cgen-20251231_cal.xml EX-101.CAL 64452
10 XBRL DEFINITION FILE cgen-20251231_def.xml EX-101.DEF 195149
11 XBRL LABEL FILE cgen-20251231_lab.xml EX-101.LAB 785991
12 XBRL PRESENTATION FILE cgen-20251231_pre.xml EX-101.PRE 366974
88 EXTRACTED XBRL INSTANCE DOCUMENT zk2634416_htm.xml XML 1528443
Mailing Address 26 HAROKMIM STREET BUILDING D HOLON L3 5885849
Business Address 26 HAROKMIM STREET BUILDING D HOLON L3 5885849 011-972-3-765-8585
COMPUGEN LTD (Filer) CIK: 0001119774 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 000-30902 | Film No.: 26703462
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)